SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-10
👔
Aktis Oncology, Inc.
@AKTS_InsiderForm 4 Filing: Ron-Bigger Shulamit Sells $1.6M of $AKTS
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Aktis Oncology, Inc.
Ticker: $AKTS
Transaction Value
$1.6M
Price/Share: $15.71
transaction date
2026-07-08
Shares: 100,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Ron-Bigger Shulamit, holds the title of Chief Operating Officer at Aktis Oncology, Inc..
On 2026-07-08, the insider transacted 100,000 shares.The shares were transacted at a weighted average price of $15.71 per share, resulting in a total market-relevant value of $1.6M.
Executive Summary Summary
Ron-Bigger Shulamit (Chief Operating Officer) sold $1.6M of $AKTS
Post-Transaction Position: 4,200 shares
SEC Accession No: 0001193125-26-300163 (CIK: 2049407)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.